The $GE IV contrast shortage harming patients could be prevented by implementing @NASEM_Health recs to secure medical product supply chains - just need to implement! https://t.co/cOvhOvtRms
USP’s #COVID19 Vaccine Handling Toolkit continues to evolve to aid frontline healthcare workers who are responding to the pandemic by administering COVID-19 #vaccines. Watch @FarahTowfic interview with @PharmacyTimes to learn more about the toolkit updates:https://t.co/cMxE83Nqiv
U.S. healthcare practitioners face unprecedented challenges as they prepare to increase #COVID19#vaccines in arms. USP has released a new COVID-19 Vaccine Handling Toolkit Learn more. https://t.co/s37wQ7NmwM #COVID19Response#HCPs
Thank you to @USPharmacopeia for hosting myself and Dr. Peter Marks for a conversation about FDA’s response to the #COVID19 pandemic. Together we can educate Americans and get our country vaccinated. #Vaccines101
The new Center for Infectious Disease Research and Policy (CIDRAP) report highlights the need for more #transparency in the medicines supply chain, especially when faced with a major disruption like #COVID19 https://t.co/jxeNhbHBWQ.
Two new peer-reviewed studies show a sharp drop in mortality among hospitalized Covid patients. The drop is seen in all groups, including older patients and those with underlying conditions, suggesting providers are getting better at treating the illness. https://t.co/tAMGC5OsPM
Everyone likes performance-based regulation & #FDA#OPQ regulatory flexibility, right? Well, is your site quality management mature enough for such flexibility? 100s of firms have signed up for free quality benchmarking reports. You should too. https://t.co/Sn4A0YaFa1
To ensure harmful levels of methanol are not present, #FDA#OPQ updated guidances to provide clarification on testing alcohol for hand sanitizers. Also, @USPharmacopeia intends to revise alcohol monographs to include a ‘Limit of Methanol’ test. https://t.co/bvFozYHRho
Increasing transparency in the medicines #SupplyChain can help regulators ensure the quality & uninterrupted supply of #medicines, shielding against disruptions like #COVID19. Read our new white paper on challenges & solutions. @ASHPOfficial@pharmacists https://t.co/xXQ2Ma6kkD
Quality matters - contract manufacturing with quality issues can cause delays...
FDA again declines approval of Nabriva's antibiotic for urinary tract infections https://t.co/9VAd97r91V
I pledge to oppose racism and hate through calling it out whenever possible, listening for inherent biases (including my own) and compassion. Join me by nominating 5 others to do so. @nbennett04@Dre_pharmd@pjschnei08@ScottKnoer @AngieFouts